Clinical Profile, Outcome, and Short-Term Follow-up of Pediatric Multisystem Inflammatory Syndrome Cases in a Tertiary Care Center of Western India

Background: There are several reports of the pediatric multisystem inflammatory syndrome associated with COVID-19 in children globally. The current Indian data on PIMS-TS associated with COVID-19 are scarce. Aims and Objectives: To describe demographic, clinical and laboratory findings, management,...

Full description

Bibliographic Details
Main Authors: Qury Nagadia, Ghosha Nilesh Pandav, Nidhi Dhamecha, Suhani Patel, Anurag Gupta, Nehal Patel
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:APIK Journal of Internal Medicine
Subjects:
Online Access:http://www.ajim.in/article.asp?issn=2666-1802;year=2024;volume=12;issue=1;spage=46;epage=50;aulast=Nagadia
_version_ 1797352306765725696
author Qury Nagadia
Ghosha Nilesh Pandav
Nidhi Dhamecha
Suhani Patel
Anurag Gupta
Nehal Patel
author_facet Qury Nagadia
Ghosha Nilesh Pandav
Nidhi Dhamecha
Suhani Patel
Anurag Gupta
Nehal Patel
author_sort Qury Nagadia
collection DOAJ
description Background: There are several reports of the pediatric multisystem inflammatory syndrome associated with COVID-19 in children globally. The current Indian data on PIMS-TS associated with COVID-19 are scarce. Aims and Objectives: To describe demographic, clinical and laboratory findings, management, and follow - up of cases of PIMS-TS. Materials and Method: We analyzed children presenting to our hospital from July 2020 to January 2021, with PIMS-TS. Cases were categorized into two subsets: Group 1 (MIS-C with shock) and Group 2 (MIS-C without shock). Coronary Z scores of >2.5 were considered as dilated. We followed all the patients at 15 days, 3 months, 6 months, and 12 months. Results: Total 11 patients with diagnosis of MIS-C were treated during this study period. Mean age of presentation was 6.5 years. All patients in Group 1 needed inotropic support and treated with steroids and intravenous immunoglobulin. Three patients required administration of tocilizumab. All these were girls <6 years with neutrophil to lymphocyte ratio (NLR) >3.5, had dilated cardiac chambers with significantly decreased ventricular ejection fractions and dilated coronary arteries. Mean length of hospital stay was around 10 days. In Group 1, gastrointestinal and cardiovascular symptoms were prominent. While in group 2, prominent symptoms were gastrointestinal and mucocutaneous. Conclusion: Most of the children in this study had coronary artery abnormalities, low incidence of RT-PCR positivity and presence of SARS–CoV-2 antibodies. Use of tocilizumab to control the inflammatory response is likely to be beneficial in steroid resistant cases. Coronaries and cardiac function reverts to normal in a month without any residual effects.
first_indexed 2024-03-08T13:13:29Z
format Article
id doaj.art-a6b549ef1fd444a1ad3a9116bc12909c
institution Directory Open Access Journal
issn 2666-1802
2666-1810
language English
last_indexed 2024-03-08T13:13:29Z
publishDate 2024-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series APIK Journal of Internal Medicine
spelling doaj.art-a6b549ef1fd444a1ad3a9116bc12909c2024-01-18T10:34:18ZengWolters Kluwer Medknow PublicationsAPIK Journal of Internal Medicine2666-18022666-18102024-01-01121465010.4103/ajim.ajim_93_22Clinical Profile, Outcome, and Short-Term Follow-up of Pediatric Multisystem Inflammatory Syndrome Cases in a Tertiary Care Center of Western IndiaQury NagadiaGhosha Nilesh PandavNidhi DhamechaSuhani PatelAnurag GuptaNehal PatelBackground: There are several reports of the pediatric multisystem inflammatory syndrome associated with COVID-19 in children globally. The current Indian data on PIMS-TS associated with COVID-19 are scarce. Aims and Objectives: To describe demographic, clinical and laboratory findings, management, and follow - up of cases of PIMS-TS. Materials and Method: We analyzed children presenting to our hospital from July 2020 to January 2021, with PIMS-TS. Cases were categorized into two subsets: Group 1 (MIS-C with shock) and Group 2 (MIS-C without shock). Coronary Z scores of >2.5 were considered as dilated. We followed all the patients at 15 days, 3 months, 6 months, and 12 months. Results: Total 11 patients with diagnosis of MIS-C were treated during this study period. Mean age of presentation was 6.5 years. All patients in Group 1 needed inotropic support and treated with steroids and intravenous immunoglobulin. Three patients required administration of tocilizumab. All these were girls <6 years with neutrophil to lymphocyte ratio (NLR) >3.5, had dilated cardiac chambers with significantly decreased ventricular ejection fractions and dilated coronary arteries. Mean length of hospital stay was around 10 days. In Group 1, gastrointestinal and cardiovascular symptoms were prominent. While in group 2, prominent symptoms were gastrointestinal and mucocutaneous. Conclusion: Most of the children in this study had coronary artery abnormalities, low incidence of RT-PCR positivity and presence of SARS–CoV-2 antibodies. Use of tocilizumab to control the inflammatory response is likely to be beneficial in steroid resistant cases. Coronaries and cardiac function reverts to normal in a month without any residual effects.http://www.ajim.in/article.asp?issn=2666-1802;year=2024;volume=12;issue=1;spage=46;epage=50;aulast=Nagadiacovid-19kawasakimultisystem inflammatory syndrome in childrenpediatric multisystem inflammatory syndromepediatric multisystem inflammatory syndrome-ts
spellingShingle Qury Nagadia
Ghosha Nilesh Pandav
Nidhi Dhamecha
Suhani Patel
Anurag Gupta
Nehal Patel
Clinical Profile, Outcome, and Short-Term Follow-up of Pediatric Multisystem Inflammatory Syndrome Cases in a Tertiary Care Center of Western India
APIK Journal of Internal Medicine
covid-19
kawasaki
multisystem inflammatory syndrome in children
pediatric multisystem inflammatory syndrome
pediatric multisystem inflammatory syndrome-ts
title Clinical Profile, Outcome, and Short-Term Follow-up of Pediatric Multisystem Inflammatory Syndrome Cases in a Tertiary Care Center of Western India
title_full Clinical Profile, Outcome, and Short-Term Follow-up of Pediatric Multisystem Inflammatory Syndrome Cases in a Tertiary Care Center of Western India
title_fullStr Clinical Profile, Outcome, and Short-Term Follow-up of Pediatric Multisystem Inflammatory Syndrome Cases in a Tertiary Care Center of Western India
title_full_unstemmed Clinical Profile, Outcome, and Short-Term Follow-up of Pediatric Multisystem Inflammatory Syndrome Cases in a Tertiary Care Center of Western India
title_short Clinical Profile, Outcome, and Short-Term Follow-up of Pediatric Multisystem Inflammatory Syndrome Cases in a Tertiary Care Center of Western India
title_sort clinical profile outcome and short term follow up of pediatric multisystem inflammatory syndrome cases in a tertiary care center of western india
topic covid-19
kawasaki
multisystem inflammatory syndrome in children
pediatric multisystem inflammatory syndrome
pediatric multisystem inflammatory syndrome-ts
url http://www.ajim.in/article.asp?issn=2666-1802;year=2024;volume=12;issue=1;spage=46;epage=50;aulast=Nagadia
work_keys_str_mv AT qurynagadia clinicalprofileoutcomeandshorttermfollowupofpediatricmultisysteminflammatorysyndromecasesinatertiarycarecenterofwesternindia
AT ghoshanileshpandav clinicalprofileoutcomeandshorttermfollowupofpediatricmultisysteminflammatorysyndromecasesinatertiarycarecenterofwesternindia
AT nidhidhamecha clinicalprofileoutcomeandshorttermfollowupofpediatricmultisysteminflammatorysyndromecasesinatertiarycarecenterofwesternindia
AT suhanipatel clinicalprofileoutcomeandshorttermfollowupofpediatricmultisysteminflammatorysyndromecasesinatertiarycarecenterofwesternindia
AT anuraggupta clinicalprofileoutcomeandshorttermfollowupofpediatricmultisysteminflammatorysyndromecasesinatertiarycarecenterofwesternindia
AT nehalpatel clinicalprofileoutcomeandshorttermfollowupofpediatricmultisysteminflammatorysyndromecasesinatertiarycarecenterofwesternindia